Forex Education Symbols

(TSX = xxx.TO, TSX-V = xxx.V)

0.085 0 (+0.000%) 10/20/2017 3:51pm
Open: 0.085 Prev Close: 0.085
High: 0.090 Low: 0.085
Volume: 151197 Market Cap: 13.06M
Year High: 0.285 Year Low: 0.080
Stock Technical Analysis
Targets Six months: 0.11    One year: 0.12
Supports Support1: 0.08   Support2: 0.07
Resistances Resistance1: 0.09    Resistance2: 0.10 
Pivot Point 0.09 
Moving Averages MA(5): 0.09      MA(20): 0.09 

MA(100): 0.09      MA(250): 0.15 
MACD MACD(12,26):       Signal(12,26,9):  
Stochastic Oscillator %K(14,3): 38.89      %D(3): 35.19 
RSI RSI(14): 47.49 
52-Week High: 0.28  Low: 0.08  Change(%): -50.0
Average Volume(K) 3-Month: 30376  10-Days: 393
Moving Averages analysis
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
Bollinger Bands Analysis
ATE.V has closed above bottom band by 43.3%. Bollinger Bands are 34.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock News
Antibe Therapeutics to Attend 2017 CPhI Worldwide Conference to Continue ...
Fri, 20 Oct 2017 10:52:30 GMT

ATE.V: Initiating Coverage of Antibe Therapeutics Inc.; Developing Next ...
Wed, 22 Mar 2017 17:26:15 GMT

Antibe Therapeutics Announces Enrollment of First Subjects in Phase 2B GI ...
Fri, 08 Sep 2017 10:52:30 GMT

Antibe Therapeutics Enters into Regional Licensing Deal
Fri, 24 Feb 2017 15:51:44 GMT

Antibe Therapeutics Announces Strategic Transactions
Tue, 06 Oct 2015 15:15:24 GMT

Antibe Therapeutics plunges 80% on suspending lead drug's phase I clinical trial
Fri, 16 Jan 2015 15:30:00 GMT

Stoxline Canada

Stock Chart Toronto

Option Calculator

EPS -0.060
EPS Est. Current Year -0.100
EPS Est. Next Year
EPS Est. Next Quarter
Forward EPS 1.#IO
Shares Out. (M) 162.97
Shares Float (M) 101.08
Book Value (p.s.) 0.030
PEG Ratio
Profit Margin -73.60
Operating Margin -68.33
Return on Assets (ttm) -31.5
Return on Equity (ttm) -119.5
Qtrly Rev. Growth -13.7
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.034
Qtrly Earnings Growth
Operating Cash Flow (M) -4.31
Levered Free Cash Flow (M) -2.63
P/E -1.42
P/E Growth Ratio
P/BV 2.83
P/S 173155632.00
P/CF -3.21